Digital Report: The Impact of NIH’s Cap on Indirect Expenses for Scientific Research—Perceptions from Academics

As the NIH’s 15% indirect cost cap faces legal challenges and sparks concerns among researchers, we connected with over 130 academic decision-makers, to gain critical insights for commercial life science companies. Scientists told us how this cap will affect them and their institutions immediately and long term, and how they are planning to make changes to cope. The report offers actionable recommendations for commercial executives and marketing/sales teams to adapt their strategies and support academic research in this evolving funding environment. Key topics include innovative solutions to reduce indirect costs, proactive communication strategies, and building strong relationships with academic customers.

Chapter 1: Introduction to NIH’s Indirect Expense Cap
Chapter 2: Understanding Indirect Costs
Chapter 3: Reaction of the Scientific Community—Survey Response
Chapter 4: Implications for Research Funding
Chapter 5: Guidance for Commercial Life Science Companies
Appendix: All verbatim quotes from respondents

Note: Your report will be delivered via email with a one-time download link. Pricing is for an individual license to download/view the PDF report. For institutional access, please contact hello@thelinusgroup.com.